X0607 3 2026-07-20 0 0002017526 Freenome, Inc. FRNM 0002146103 Lin Cheng-Ho Jimmy false C/O FREENOME, INC. 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 true Chief Scientific Officer Common Stock 410154 D Stock Option (right to buy) 4.85 2029-07-30 Common Stock 10849 D Stock Option (right to buy) 4.85 2029-10-15 Common Stock 145561 D Stock Option (right to buy) 15.91 2032-06-21 Common Stock 140685 D Stock Option (right to buy) 11.88 2033-02-17 Common Stock 49651 D Stock Option (right to buy) 18.24 2034-02-15 Common Stock 78331 D Stock Option (right to buy) 14 2035-03-10 Common Stock 150019 D The shares subject to this option are fully vested. 25% of the shares subject to this option shall vest and become exercisable on February 2, 2024 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments commencing from February 16, 2024, subject to the Reporting Person's continued service on each such vesting date. 25% of the shares subject to this option shall vest and become exercisable on February 15, 2026 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. This option was previously amended, pursuant to which the exercise price of the option will be automatically reduced to $8.45 upon the occurrence of certain events. Exhibit 24 - Power of Attorney /s/ Thomas Fitzpatrick, Attorney-in-Fact 2026-07-27